Page 6 - Best Chemotherapy doctors: TOP 156 doctors

Professor Jair Bar, MD, PhD, is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He leads the Thoracic Oncology Unit. He treats lung cancer, including advanced non-small cell cases. His care includes medical oncology, radiotherapy, immunotherapy, and targeted therapy.

He runs a translational research lab focused on resistance to immunotherapy. He has published on exhaled-breath cancer metabolism and on angiogenesis inhibition in lung cancer.

He has chaired the Israel Lung Cancer Group since 2003. He is a member of the Israel Society of Clinical Oncology and Radiotherapy, the American Society of Clinical Oncology, and the American Association for Cancer Research. He is board-certified in Medical Oncology and Radiotherapy Oncology. He is a Senior Lecturer at Tel Aviv University.

Dr. Abraham Avigdor, MD, is Director of the Institute of Hematology and Co‑Director of the Hematology & Bone Marrow Transplantation Division at Sheba Medical Center. He is an international leader in lymphoma, CAR‑T, and advanced hemato‑oncology with more than 35 years of experience. His clinical focus includes lymphomas, multiple myeloma, and complex blood cancers.

He is a pioneer in CAR‑T integration. He leads cellular therapy and bone marrow transplantation programs (autologous and allogeneic). He also advances stem cell therapies and precision diagnostics, including PET/CT‑based prognostics. His work includes immunotherapy and targeted regimens and the development of innovative, data‑driven protocols.

He collaborates with LYSA, EMCL, and international PET groups. He has authored more than 130 publications. Key roles include Founder and President of the Israeli Lymphoma Working Group, former Chair of the Israeli Lymphoma Study Group, and Senior Lecturer at Tel Aviv University. Education: MD, Ben‑Gurion University; residency, Sheba Medical Center; postdoctoral fellowship, Weizmann Institute. Awards include the Knesset Prize, the Israeli Ministry of Health Award, and the Sackler Prize.

Assoc. Prof. Ayse Irem Yasin specializes vergewis in medical oncology with extensive experience treating various cancers at Medipol Acibadem District Hospital.

• Board-certified in medical oncology with ESMO certification
• Specializes in breast, lung, and gastrointestinal cancers
• Trained internationally at prestigious institutions like Cleveland Clinic and Harvard Medical School
• Completed fellowship in medical oncology at Bezmialem Vakif University

Prof. Elad Jacoby, MD, heads the Pediatric Cell Therapy Center at Sheba Medical Center. He is the Medical Director of the Advanced Biotherapy Center. He is a pioneer of pediatric CAR T‑cell therapy in Israel. He led one of the first national leukemia programs. He has almost 20 years of clinical and research experience.

He specializes in CAR T‑cell therapy, bone marrow and stem cell transplantation, and high‑risk pediatric leukemias and lymphomas. He leads international clinical trials and has authored over 240 publications. His collaborations include Johns Hopkins Hospital and the U.S. National Cancer Institute. He is an Associate Professor at Tel Aviv University. He received his MD from Tel Aviv University, completed residency at Sheba Medical Center, and fellowships at Johns Hopkins and the National Cancer Institute. He is board‑certified in Pediatrics and in Pediatric Hematology and Oncology. He serves on the IBFM CAR T‑Cell Taskforce and the Sheba Institutional Review Board. He leads the integration of CAR T‑cell therapy with transplantation.

Leading expert in chronic lymphocytic leukemia (CLL) – Professor Bosch has pioneered new treatments and technologies for hematological diseases.

• Conducts over 80 clinical trials from phase 1 to phase 3
• Published more than 100 articles in top medical journals
• Head of Hematology at IOB Institute of Oncology
• President of the Spanish group for CLL study (GELLC)

Principal Investigator in clinical trials for ovarian, cervical, and endometrial cancer – Dr. Oaknin leads groundbreaking research at Hospital Quiron Barcelona.

• Author of 100+ publications on gynecological tumors
• Executive board member of GEICO Group (Spanish Ovarian Cancer Research Group)
• Faculty member for Gyn-Track in ESMO
• Spanish representative in GCIG Group's Cervical Committee

Specializes in breast cancer and melanoma treatments, focusing on hormone therapy resistance and immunotherapy. Works at Hospital Quiron Barcelona.

• Participated in trials leading to new drug approvals for breast cancer
• Involved in studies that revolutionized melanoma treatment
• Member of Breast Cancer and Melanoma Units at Vall d’Hebron
• Focuses on holistic patient care

Dr. Prat leads SOLTI as president, designing clinical trials for breast cancer treatments. His research focuses on gene expression and molecular subtypes.

• Head of Translational Genomics and Targeted Therapeutics at IDIBAPS
• Co-founder of Reveal Genomics, holds three patents
• Over 160 publications with an H-Index of 51
• Medical oncology fellowship at Vall d´Hebron Institute of Oncology
• Tenure-Track Professor at Barcelona University

Dr. Graus is a leading expert in paraneoplastic neurological syndromes, having defined the first strict diagnostic criteria for these conditions.

• 44 years of experience of experience in neuro-oncology
• Former Chief of Neurology at Hospital Clinic Barcelona
• Founder and past president of the European Association of Neuro-Oncology
• Specializes in neurotoxicities from cancer treatments
• Honorary doctorate from Lyon University

Specialized in gynecological oncology and chemotherapy at Samsung Medical Center.

• Focused expertise in gynecological cancers and chemotherapy treatments
• Works at Samsung Medical Center, a leading healthcare institution
• Oncogynecologist with a strong background in women's cancer care

Israel's leading specialist in lung cancer immunotherapy – Prof. Peled heads the Thoracic Cancer Unit at Davidoff Cancer Center.

• Fellowship-trained in lung cancer at University of Colorado Denver
• Received MERIT award from American Society of Clinical Oncology (ASCO)
• Chairs IASLC's Early Detection & Prevention Committee
• Specializes in personalized medicine and immuno-oncology for lung cancer

Internationally recognized pediatric oncology expert – Prof. Ben-Harush leads the Pediatric Division at Ruth Rappaport Children's Hospital.

• Specializes in pediatric oncology and bone marrow transplantation
• Recipient of the Chevalier de la Legion d'Honneur in France
• Named one of the world's most caring doctors by the World Medical Association
• Member of children's oncology groups in the USA and Europe

Radiotherapy specialist with a dedicated focus on oncology at Rambam Medical Center.

• Specializes in chemotherapy and radiotherapy treatments
• Works at Rambam Medical Center, a leading healthcare institution
• Committed to personalized cancer care plans

Head of the Breast Cancer Treatment Center – Prof. Jablonski-Perec brings decades of specialized expertise to Hadassah Medical Center.

• Received medical training at Sloan-Kettering Cancer Center in New York
• Professor of Oncology at Hebrew University since 2006
• Former Head of the Institute of Oncology
• Member of multiple international cancer societies

Dr. Spielberg is a specialized oncohematologist treating patients at Assuta Medical Center.

• Focuses exclusively on chemotherapy treatments
• Works at one of Israel's leading medical centers
• Dedicated to personalized treatment plans for each patient

Dr. Zhevelyuk specializes in oncology and radiology at Assuta Medical Center.

• Experienced in chemotherapy treatments
• Works at a leading medical center
• Focuses on patient-centered care

Chief Physician of the Oncology Center at Assuta Medical Center – leading expert in chemotherapy treatments.

• Specializes in oncology with extensive experience in chemotherapy protocols
• Holds a leadership role at a top-tier medical center
• Dedicated to personalized treatment plans for each patient

Assoc. Prof. Murat Ayhan leads cutting-edge chemotherapy research at Liv Hospital Vadistanbul, with multiple international clinical trials.

• Specializes in breast, lung, and colorectal cancers
• Active in Phase II and III clinical trials for novel treatments
• Published 25+ research papers in peer-reviewed oncology journals
• Member of ESMO and Turkish Society of Medical Oncology

Specializes in chronic leukemia, lymphoma, and multiple myeloma – Dr. Dogu brings deep expertise in hematologic cancers to Liv Hospital Ulus.

• 36 years of experience of experience in hematology and internal medicine
• Published 32 articles in international peer-reviewed journals
• Board member of The Society of Hematological Education and Research
• Associate Professor at Istanbul Training and Research Hospital